18F-FDG PET/CT and 68Ga-DOTA-FAPI-04 PET/CT Findings of Myeloid Sarcoma. (11th March 2023)

• Record Type: Journal Article
• Authors: Liu, Wei; Yang, Xiao; Chen, Liming; Chen, Yue; Xu, Tingting
• Is Part Of: Clinical nuclear medicine. Volume 48:Number 3(2023)
• Page Start: 278
• Page End: 279
• Publication Date: 2023-03-11
• Subjects: myeloid sarcoma -- 18F-FDG -- fibroblast activation protein -- 68Ga-FAPI -- PET/CT; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000004488
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract: A 28-year-old woman presented with a 2-month history of swelling and pain in the chest wall. An irregular soft tissue mass in the chest wall and mediastinum was showed on chest CT. 18 F-FDG PET/CT revealed obvious FDG uptake in the mass. Subsequently, the patient was participated in a 68 Ga-DOTA-FAPI-04 PET/CT tumor clinical trial. 68 Ga-DOTA-FAPI-04 PET/CT also showed elevated tracer uptake in the mass. Biopsy of the mass confirmed a diagnosis of myeloid sarcoma.